COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination.
作者信息
Wadei Hani M, Gonwa Thomas A, Leoni Juan C, Shah Sadia Z, Aslam Nabeel, Speicher Leigh L
机构信息
Department of Transplant, Mayo Clinic, Jacksonville, Florida, USA.
Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida, USA.
出版信息
Am J Transplant. 2021 Oct;21(10):3496-3499. doi: 10.1111/ajt.16618. Epub 2021 May 18.
Abstract
摘要
相似文献
1
COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination.
Am J Transplant. 2021 Oct;21(10):3496-3499. doi: 10.1111/ajt.16618. Epub 2021 May 18.
2
Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients.
Am J Transplant. 2022 Feb;22(2):673-675. doi: 10.1111/ajt.16855. Epub 2021 Oct 5.
3
Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients.
Am J Transplant. 2021 Aug;21(8):2916-2918. doi: 10.1111/ajt.16713. Epub 2021 Jul 10.
4
Zero health-care-associated respiratory viral infections among solid organ transplant recipients: Infection prevention outcomes during COVID-19 pandemic.
Am J Transplant. 2021 Jun;21(6):2311-2313. doi: 10.1111/ajt.16499. Epub 2021 Feb 17.
5
Adverse events after SARS-CoV-2 vaccination in solid organ transplant recipients: A systematic review.
Transpl Infect Dis. 2022 Dec;24(6):e13936. doi: 10.1111/tid.13936. Epub 2022 Sep 6.
6
Risk of severe COVID in solid organ transplant recipient.
Rev Esp Quimioter. 2023 Nov;36 Suppl 1(Suppl 1):15-17. doi: 10.37201/req/s01.04.2023. Epub 2023 Nov 24.
7
COVID-19 vaccination in solid-organ transplant recipients: generating new data as fast as possible, but taking clinical decisions as slow as necessary.
Clin Microbiol Infect. 2021 Aug;27(8):1070-1071. doi: 10.1016/j.cmi.2021.06.018. Epub 2021 Jun 19.
8
Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
Transpl Infect Dis. 2022 Apr;24(2):e13779. doi: 10.1111/tid.13779. Epub 2022 Jan 31.
9
Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients.
Am J Transplant. 2021 Aug;21(8):2913-2915. doi: 10.1111/ajt.16607. Epub 2021 May 7.
10
SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients.
Am J Transplant. 2021 Dec;21(12):4105. doi: 10.1111/ajt.16744. Epub 2021 Jul 16.
引用本文的文献
1
Who is the Candidate? The Heart Transplant Evaluation Process.
Methodist Debakey Cardiovasc J. 2025 May 15;21(3):13-24. doi: 10.14797/mdcvj.1512. eCollection 2025.
2
Comparison of Post-Vaccination Response (Humoral and Cellular) to BNT162b2 in Clinical Cases, Kidney and Pancreas Transplant Recipient with Immunocompetent Subjects over Almost Two Years of Parallel Monitoring.
Vaccines (Basel). 2024 Jul 26;12(8):844. doi: 10.3390/vaccines12080844.
3
COVID-19 vaccine updates for people under different conditions.
Sci China Life Sci. 2024 Nov;67(11):2323-2343. doi: 10.1007/s11427-024-2643-1. Epub 2024 Jul 29.
4
A review of the clinical characteristics and management of immunosuppressed patients living with HIV or solid organ transplants infected with SARS-CoV-2 omicron variants.
Front Public Health. 2024 Feb 22;12:1327093. doi: 10.3389/fpubh.2024.1327093. eCollection 2024.
5
Differences in Responses of Immunosuppressed Kidney Transplant Patients to Moderna mRNA-1273 versus Pfizer-BioNTech.
Vaccines (Basel). 2024 Jan 17;12(1):91. doi: 10.3390/vaccines12010091.
6
Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis.
Front Immunol. 2023 Sep 5;14:1145081. doi: 10.3389/fimmu.2023.1145081. eCollection 2023.
7
COVID-19 Prevention in Solid Organ Transplant Recipients: Current State of the Evidence.
Infect Dis Clin North Am. 2023 Sep;37(3):459-473. doi: 10.1016/j.idc.2023.03.002. Epub 2023 Mar 22.
8
Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.
Open Forum Infect Dis. 2023 Apr 13;10(5):ofad200. doi: 10.1093/ofid/ofad200. eCollection 2023 May.
9
Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19.
World J Clin Cases. 2023 Apr 6;11(10):2140-2159. doi: 10.12998/wjcc.v11.i10.2140.
10
Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients.
Front Immunol. 2023 Mar 31;14:1172477. doi: 10.3389/fimmu.2023.1172477. eCollection 2023.
本文引用的文献
1
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
Kidney Int. 2021 Jun;99(6):1487-1489. doi: 10.1016/j.kint.2021.03.014. Epub 2021 Mar 26.
2
SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.
N Engl J Med. 2021 May 6;384(18):1774-1775. doi: 10.1056/NEJMc2101927. Epub 2021 Mar 23.
3
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385.
4
Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample.
Rom J Intern Med. 2021 Mar 5;59(1):10-42. doi: 10.2478/rjim-2020-0034. Print 2021 Mar 1.
5
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.
Am J Transplant. 2020 Jul;20(7):1800-1808. doi: 10.1111/ajt.15941. Epub 2020 May 10.
6
Covid-19 and Kidney Transplantation.
N Engl J Med. 2020 Jun 18;382(25):2475-2477. doi: 10.1056/NEJMc2011117. Epub 2020 Apr 24.
Zotero 插件